Lifeward (LFWD) Free Cash Flow Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 22.80% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -27.72% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -0.27% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 77.20% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -20.37% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.32% |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | 10.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.91% |
| Dec 31, 2025 | 3.28% |
| Sep 30, 2025 | 5.64% |
| Jun 30, 2025 | -1.92% |
| Mar 31, 2025 | 1.22% |
| Dec 31, 2024 | -15.36% |
| Sep 30, 2024 | -20.01% |
| Jun 30, 2024 | -21.02% |
| Mar 31, 2024 | -34.10% |
| Dec 31, 2023 | -22.90% |
| Sep 30, 2023 | -41.00% |
| Jun 30, 2023 | -3.11% |
| Mar 31, 2023 | -6.35% |
| Dec 31, 2022 | -2.78% |
| Sep 30, 2022 | -12.12% |
| Jun 30, 2022 | 0.17% |
| Mar 31, 2022 | -10.32% |
| Dec 31, 2021 | 0.32% |
| Sep 30, 2021 | 6.06% |
| Jun 30, 2021 | 7.79% |
| Mar 31, 2021 | 14.13% |
| Dec 31, 2020 | 23.18% |
| Sep 30, 2020 | 23.11% |
| Jun 30, 2020 | 14.84% |
| Mar 31, 2020 | 10.36% |
| Dec 31, 2019 | 18.23% |
| Sep 30, 2019 | 21.27% |
| Jun 30, 2019 | 18.51% |
| Mar 31, 2019 | 15.57% |
| Dec 31, 2018 | 29.01% |
| Sep 30, 2018 | -36.19% |
| Jun 30, 2018 | -39.04% |
| Mar 31, 2018 | 8.37% |
| Dec 31, 2017 | -25.91% |
| Sep 30, 2017 | -44.25% |
| Jun 30, 2017 | -49.77% |
| Dec 31, 2016 | -34.20% |
| Sep 30, 2016 | -71.28% |